@article{article, title = {{Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England}}, publisher = {{Springer Science and Business Media LLC}}, url = {{http://dx.doi.org/10.1007/s40258-024-00924-x }}, year = {{2024}}, month = {{11}}, author = {{Woods B and Kearns B and Schmitt L and Jankovic D and Rothery C and Harnan S and Hamilton J and Scope A and Ren S and Bojke L and Wilcox M et al}}, doi = {{10.1007/s40258-024-00924-x}}, journal = {{Applied Health Economics and Health Policy}}, note = {{Accessed on 2025/07/07}}}